10.14

0.00% 0.00

After Hours: 10.14

Drugs Made In America Acquisition Ii Corp (DMII)

Overview News Price History Discussions Forecast

Drugs Made In America Acquisition Ii Corp stock is traded at $10.14, with a volume of 317. It is up +0.00% in the last 24 hours and up +0.30% over the past month. Drugs Made In America Acquisition II Corp is a blank check Company.

Previous Close:

$10.14

Open:

$10.14

24h Volume:

317

Relative Volume:

0.00

Market Cap:

$645.92M

Revenue:

Net Income/Loss:

$8.58M

P/E Ratio:

75.67

EPS:

0.134

Net Cash Flow:

$-1.11M

1W Performance:

+0.00%

1M Performance:

+0.30%

6M Performance:

+1.60%

1Y Performance:

+0.00%

1-Day Range:

$10.14

1-Week Range:

$10.12

$10.21

52-Week Range:

$9.87

$10.21

Drugs Made In America Acquisition Ii Corp Stock (DMII) Company Profile

Name

Drugs Made In America Acquisition Ii Corp

Sector

Financial (5820)

Industry

Shell Companies (242)

Phone

954-870-3104

Address

420 LEXINGTON AVENUE, NEW YORK

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

DMII's Discussions on Twitter

Compare DMII vs LION, XXI, UMAC, CCXI, AAC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DMII Drugs Made In America Acquisition Ii Corp	10.14	645.92M	0	8.58M	-1.11M	0.134
LION Lionsgate Studios Corp	11.40	3.41B	2.63B	-175.60M	11.40M	-0.7173
XXI Twenty One Capital Inc	6.01	3.48B	0	4.35M	456.40K	0.3397
UMAC Unusual Machines Inc	23.98	1.30B	17.25M	-5.64M	-40.16M	-0.3337
CCXI Churchill Capital Corp Xi	13.97	783.70M	0	0	0	0.0647
AAC Ares Acquisition Corporation	10.06	761.82M	0	-10.01M	-1.23M	-0.08

Drugs Made In America Acquisition Ii Corp Stock (DMII) Latest News

Aug 20, 2026

Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingBuy Signal Reports - vinanet.vn

Aug 20, 2026

Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionMarket Neutral Pair - vinanet.vn

Aug 20, 2026

Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Chart, News & Analysis - Securities.io

Aug 20, 2026

Aug 18, 2026

Drugs (DMIIR) Daily Review: Closes with Little Net Change at $0.10 in Latest Trading; Level-Based View: the Current Price Sits Inside the Supplied Technical Range at the CloseMerger Arbitrage - Vinanet

Aug 18, 2026

Aug 16, 2026

DMII Holds at $10.13: Drugs Made In America Acquisition II Corp. Trades Flat Amid SPAC Market ConsolidationAdvance Decline Volume - dars.gov.et

Aug 16, 2026

Aug 14, 2026

Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat

Aug 14, 2026

DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight RangeGamma Exposure - Vinanet

Aug 14, 2026

Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan

Aug 14, 2026

Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 14, 2026

Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan

Aug 14, 2026

Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan

Aug 14, 2026

DMAA Holds at $10.69 as SPAC Awaits Definitive Acquisition TargetPCR Moving Average - vinanet.vn

Aug 14, 2026